OncoSystems Hub is a trustworthy global collaboration tracking the technologies reshaping cancer care, and the question of whether health systems can put them within reach of everyone who needs them.
Cancer care is advancing faster than ever — new molecular diagnostics, targeted drugs, cell therapies, vaccines, and advances in screening, imaging, surgery and radiation. But a breakthrough that a health system cannot afford, staff or fairly distribute is a breakthrough only on paper. Meanwhile, patients are sometimes treated more intensively than the evidence warrants, adding harm and cost without adding benefit.
We sit at that intersection. We follow innovation closely, and we hold it to a simple test: what can and should health systems do to ensure access, improve population outcomes, and avoid inequities? That is our prerogative, and the lens on everything we publish and build.
Independent and transparent. Everything we share is sourced and referenced — a reliable signal in a noisy, misinformation-prone field.
We look past the trial result to financing, workforce, pathways and equity — the conditions that decide whether innovation reaches people.
We champion de-intensification where the evidence supports it: less treatment, same outcomes, less harm and cost.
We build open tools so teams can act on evidence — mapping access, tracking evidence, and assessing readiness.
From the laboratory to the ministry: molecular diagnostics and precision medicine, cancer drugs and cell therapies, vaccine development, screening, imaging, surgery and radiation — always paired with the access, affordability and equity questions that determine their real-world impact.
We are a global network of clinicians, researchers, health-system leaders and policy specialists who share a conviction that better outcomes come from better systems, not just better science. If that resonates — as a contributor, a partner, or a reader — we'd welcome you.
Contribute a brief, collaborate on a tool, or bring a challenge from your own system. Tell us what you're working on.
Get in touch